SION
Sionna Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Michael Cloonan
IPO Date
2025-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Sionna Therapeutics, Inc.
CEO
Michael Cloonan
IPO Date
2025-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US